Zobrazeno 1 - 10
of 1 263
pro vyhledávání: '"Antimigraine Agents"'
Publikováno v:
Tropical Journal of Pharmaceutical Research. Jul2018, Vol. 17 Issue 7, p1439-1444. 6p.
Publikováno v:
In Havard'S Nursing Guide to Drugs Edition: Eleventh Edition. 2022:555-566
Publikováno v:
Tropical Journal of Pharmaceutical Research; Vol 17, No 7 (2018); 1439-1444
Purpose : To determine the dispensing patterns of antimigraine agents in a private healthcare setting, focusing on seasonal variations in prescribing. Methods : A retrospective, cross-sectional drug utilization study was conducted using a South Afric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::370defcbe3daa7a89ba005e83ebe5834
https://doi.org/10.4314/tjpr.v17i7.30
https://doi.org/10.4314/tjpr.v17i7.30
Publikováno v:
In Havard's Nursing Guide to Drugs Edition: Tenth Edition. 2017:506-514
Autor:
Rajan Mittal, Sushma Srivastava
Publikováno v:
Drug Screening Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::388d3a271c1fa11430f4f1c6a2d86c72
https://doi.org/10.5005/jp/books/12723_32
https://doi.org/10.5005/jp/books/12723_32
Autor:
Pierluigi Navarra, Giuseppe Tringali
Publikováno v:
Peptides. 116
Calcitonin gene-related peptide (CGRP) is a peptide neurotransmitter with potent vasodilating properties. CGRP is believed to play a primary role in the pathogenesis of migraine. As such, CGRP and its receptors are obvious druggable targets for novel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70c43bb04a3fce85e3b2c71762f2d311
https://pubmed.ncbi.nlm.nih.gov/31018157
https://pubmed.ncbi.nlm.nih.gov/31018157
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joseph P Yevich
Publikováno v:
Expert Opinion on Therapeutic Patents. 7:511-521
The patent literature pertaining to agents for the treatment of migraine headache and related disorders has been reviewed for the period of July 1, 1995 to December 31, 1996. Included are patents on serotonergic agents, such as 5-hydroxytryptamine 1D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bb9b01a2930dea85fa8d003d8ee0ac8
https://doi.org/10.1517/13543776.7.5.511
https://doi.org/10.1517/13543776.7.5.511
Autor:
Joseph P Yevich
Publikováno v:
Expert Opinion on Therapeutic Patents. 5:1077-1086
The patent literature pertaining to agents for the treatment of migraine headache and related disorders has been reviewed for the period of July 1, 1994 to June 30, 1995. Included are patents on serotonergic agents, i.e. 5-HT1D agonists, 5-HT2 recept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5dfcfaddafdec7063dd67cb9c39137c0
https://doi.org/10.1517/13543776.5.10.1077
https://doi.org/10.1517/13543776.5.10.1077